Wed, December 5, 2012
Tue, December 4, 2012
Mon, December 3, 2012
Sun, December 2, 2012
Sat, December 1, 2012
Fri, November 30, 2012
Thu, November 29, 2012
Wed, November 28, 2012
Tue, November 27, 2012
Mon, November 26, 2012
Sun, November 25, 2012
Fri, November 23, 2012
Thu, November 22, 2012
Wed, November 21, 2012
Tue, November 20, 2012
Mon, November 19, 2012
Sat, November 17, 2012
Fri, November 16, 2012
Thu, November 15, 2012
Wed, November 14, 2012
Tue, November 13, 2012
Mon, November 12, 2012

Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. -annual-piper-jaffray-healthcare-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference -- ALISO VIEJO, Calif., Nov. 21, 2012 /PRNewswire/ --

ALISO VIEJO, Calif., Nov. 21, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) today announced that company management will present an overview of the company at the 24th Annual Piper Jaffray Healthcare Conference in New York, NY.

  • Location: Palace Hotel, New York, NY
  • Presentation date: Tuesday, November 27, 2012
  • Presentation time: 1:30 p.m. ET

A live webcast and 30-day archive of this presentation will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
[ ir@avanir.com ]
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.avanir.com ]

Publication Contributing Sources